ClinicalTrials.gg

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Amneal Pharmaceuticals, Inc. clinical trials

Its pipeline, or its studies — you choose. Free with an account during the beta.

The registry lists 46 studies whose lead sponsor is Amneal Pharmaceuticals, Inc. or one of 4 companies grouped under it. 5 are recruiting or about to start. Per ClinicalTrials.gov, last updated Oct 27, 2026.

Our grouping of 5 registry names, not the registry’s. See them and correct one ↓

Compare Amneal Pharmaceuticals with Hoffmann-La Roche and Eli Lilly →

Pipeline: 5 programs

Each counted once: 5 with a study Amneal Pharmaceuticals, Inc. leads registered in the last two years.

  • Phase 1
  • Phase 3
  • Phase 4 (approved, new studies)

The 1 phase-3 program — sign in to see them, free: with every program, filter by condition or phase and sort by first study or primary completion.

“Registry” is the highest phase of Amneal Pharmaceuticals, Inc.’s own registered studies; Amneal Pharmaceuticals, Inc.’s own pipeline document is not read yet. “Primary completion” is the earliest date still ahead among its live studies when the main measure’s data collection ends, as the registry states it (most are estimates); results come later, if they are announced. Programs are read from ClinicalTrials.gov, joined across names by rules and decisions each recorded with its evidence.

What it is testing

The drugs Amneal Pharmaceuticals, Inc.’s studies test, most open studies first — 17 drugs with a page of their own. Each count opens the studies in search.

Open now Not open: under way, finished or stopped

Show 7 more

Coming up

1 of Amneal Pharmaceuticals, Inc.’s studies under way reach primary completion within a year, all of them phase 3. The dates are the sponsor’s own estimates, which often move.

Phase 3 Other phases

  1. N’26
  2. D
  3. J’27
  4. F
  5. 1M
  6. A
  7. M
  8. J
  9. J
  10. A
  11. S
  12. O
  13. N

Add it to your calendar (.ics) → With an account.

What changed recently

From the registry's own updates since Oct 19, 2026.

All 46 at a glance

Where each study is in its life, its phase and its countries. Each count opens them in search.

  • Open now511%
  • Completed3780%
  • Stopped early12%
  • Status unknown or other37%

Phase

  • Phase 324
  • Phase 113
  • Phase 210
  • Phase 41

Where

  • United States33
  • India10
  • Canada6
  • Germany5
  • Ukraine4
  • Poland4

Over the years

  1. 07
  2. 08
  3. 509
  4. 10
  5. 11
  6. 12
  7. 13
  8. 14
  9. 15
  10. 16
  11. 17
  12. 18
  13. 19
  14. 20
  15. 21
  16. 22
  17. 23
  18. 24
  19. 25
  20. 126

By the year each study started; 4 started before 2007. 2026 so far in the lighter column.

Registry sponsor names on this page

Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.

Tell us about a missing company
No account needed. Please leave out personal details.

Each name exactly as ClinicalTrials.gov lists it, and how it relates to Amneal Pharmaceuticals, Inc.

  • Impax Laboratories, LLC
    Acquired — became part of Amneal Pharmaceuticals, Inc., May 4, 2018 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    20 studies →
  • Amneal Pharmaceuticals, LLC
    Same company
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    13 studies
  • Kashiv BioSciences, LLC
    Acquired — became part of Amneal Pharmaceuticals, Inc., Aug 10, 2026 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    9 studies →
  • Amneal Ireland Limited
    Regional office
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    3 studies →
  • Amneal Pharmaceuticals Co. India Private Limited
    Regional office
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    1 study →

Focus areas

Conditions Amneal Pharmaceuticals, Inc. leads ten or more studies in, by study count. A broader condition is left out when almost all its studies are already in a narrower one listed here.

Studies

Recruiting first, then most recently updated. Showing 46 of 46.